IN THE HIGH COURT OF DELHI AT NEW DELHI
C. Hari Shankar, J.
J. B. Chemicals And Pharmaceuticals Ltd. – Appellant
Versus
Okvik Lifesciences & Anr. – Respondents
CS(COMM) 591 of 2022 & I.A. 13635 of 2022
Decided On : 13-02-2023
Trademark Infringement - Settlement Agreement - The court resolved the dispute between the parties through a settlement agreement, where Defendant No.1 acknowledged the Plaintiff's ownership of the trademark RANTAC and undertook to cease manufacturing, marketing, or selling pharmaceutical preparations under the mark RANTAC. Defendant No.1 also agreed to destroy all infringing goods, pay damages to the Plaintiff, and refrain from breaching the settlement in the future.
Fact of the Case:
The dispute between the parties was resolved through a settlement agreement facilitated by the Delhi High Court Mediation and Conciliation Centre. Defendant No.1 acknowledged the Plaintiff's ownership of the trademark RANTAC, agreed to cease infringing activities, and paid damages to the Plaintiff.
Finding of the Court:
The court found that the settlement agreement resolved the dispute between the parties, and as a result, there was nothing left for adjudication in the present suit. The court decreed the suit in terms of the settlement agreement and disposed of the miscellaneous application.
Issues: The main issue was the infringement of the Plaintiff's trademark RANTAC by Defendant No.1, which led to the legal dispute between the parties.
Ratio Decidendi: The court's decision was based on the settlement agreement and the acknowledgments and undertakings made by Defendant No.1, which effectively resolved the dispute and led to the decree in favor of the Plaintiff.
Final Decision: The court decreed the suit in terms of the settlement agreement and disposed of the miscellaneous application. The Plaintiff was entitled to be refunded the court fees, if any, deposited by it.
ORDER (Oral)
1. The dispute between the parties stands resolved with the interjection of the Delhi High Court Mediation and Conciliation Centre vide settlement agreement dated 6th February 2023 which has been placed on record. The terms of settlement read thus:
"i. Defendant No.1 acknowledges that the Plaintiff is the owner and registered proprietor of the well-known trademark RANTAC under the Trade Marks Act, 1999 as well as under common law.
ii. Defendant No.1 including their distributors, marketer, agents, CNF agents, stockists or anyone who is acting on their behalf, undertake to cease the manufacturing, marketing or selling of pharmaceutical preparations under the mark RANTAC/RANTAC 150/RANTAC DSR or any deceptively similar variant of the Plaintiff's trademark RANTAC either as a standalone mark or as a prefix in a composite mark or in any manner whatsoever amounting to infringement of the Plaintiff's registered trademark (and its variants) and/or passing off. Defendant No. 1 further undertakes to not to use the mark RANTAC in any manner whatsoever.
iii. That Defendant No.1 undertakes that they have not filed any application for registration of the mark RANTAC and or any mark containing RANTAC and/or device or any other mark deceptively similar to the trademark RANTAC. That Defendant No.1 also undertakes that they will not file any application for registration of the mark RANTAC or any mark containing RANTAC and/or any other similar mark whether in the form of a word, label or other composite mark in respect of any goods or services whatsoever.
iv. Defendant No.1 undertakes to destroy all the infringing goods in its possession including promotional material, strips, cartons, containers, labels, stationery or any other printed matter currently in their possession bearing the marks RANTAC/RANTAC 150/RANTAC DSR or any of its variants which are deceptively similar to the Plaintiff's trademarks. The Defendant No.1 shall also disclose the quantity destroyed by them.
v. Defendant No.1 also undertakes to communicate and facilitate handover of the seized products (59 Strips) from Defendant No.2, its manufacturer, to the Plaintiff for purposes of destruction. That Defendant No.1 further undertakes to ensure that Defendant No.2 shall not manufacture pharmaceutical preparations under the mark RANTAC/RANTAC 150/RANTAC DSR or any deceptively similar variant of the Plaintiffs trademark RANTAC.
vi. In consideration of the above, Defendant No. 1 shall pay a sum of INR 2,25,000/- as damages incurred to the Plaintiff via Demand Draft. Defendant No.1 has agreed that Demand Draft shall be in the name of the Plaintiff and handed over to the same to Plaintiff's counsel at the time of recordal of present Settlement Agreement before court.
vii. Defendant No.1 undertakes not to commit any breach of any of the undertakings in this memorandum of compromise in future in any manner whatsoever. Should the Defendant No.1 be found in breaeh of the present memorandum of compromise at any future date, they agree to pay a sum of Rs.1,00,000/- per infringing product or any other article sold by the Defendant No.1 either on an online pharmacy platform, physical chemist stores or independently.
viii. The aforesaid undertakings have been signed by Defendant No.1 through Ms. Astha Arora in her capacity as the Proprietor/Partner of Defendant No.1. The undertakings given herein shall be binding on all the legal heirs, affiliates, sister concerns, employees, principals, business partners, representatives and assigns-in-business of Defendant No.1. Similarly, Mr. Vishal Vithal Chavan, constituted attorney of the Plaintiff, signs this compromise on behalf of the Plaintiff fully empowered to bind the Plaintiff to the terms of this compromise and hereby do so."
2. Learned Counsel for the parties who are present in Court undertake on behalf of their respective clients to abide by the terms of settlement.
3. Mr. Prithvi Gulati, learned Counsel for the plaintiff submits that tho
The central legal point established in the judgment is the effectiveness of a settlement agreement in resolving a trademark infringement dispute and leading to a decree in favor of the aggrieved part....
The main legal point established in the judgment is the binding nature of a settlement agreement reached between parties, which can lead to the court decreeing the suit in terms of the settlement and....
Settlement agreements can be used to resolve disputes without delving into the merits of the case, and the court may decree the suit in terms of the settlement agreement.
Settlement agreements can effectively resolve disputes in trademark infringement cases, allowing parties to acknowledge rights and agree on actions to prevent future violations.
Settlement agreements can effectively resolve disputes and render legal proceedings unnecessary for adjudication.
The court upheld the settlement agreement as lawful and binding, leading to the decree of the suit in terms of the settlement.
Settlement agreements regarding trademark disputes are binding and enforceable, and parties must comply with the specified terms regarding the acknowledgment of ownership and cessation of infringing ....
Enforcement of Settlement Agreement
The central legal point established in the judgment is the approval and enforcement of a Settlement Agreement to resolve trademark infringement disputes.
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.